Detalhe da pesquisa
1.
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers.
Hepatology
; 77(6): 1943-1957, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36052732
2.
Type I Interferon: Monkeypox/Mpox Viruses Achilles Heel?
Adv Exp Med Biol
; 1451: 125-137, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38801575
3.
Subversion of Programed Cell Death by Poxviruses.
Curr Top Microbiol Immunol
; 2021 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33507400
4.
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations.
Dig Dis Sci
; 67(8): 3797-3805, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34773565
5.
Optimization of translation enhancing element use to increase protein expression in a vaccinia virus system.
J Gen Virol
; 102(8)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382930
6.
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.
J Virol
; 93(3)2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30429340
7.
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.
J Virol
; 93(3)2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30429343
8.
Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3.
Proc Natl Acad Sci U S A
; 114(43): 11506-11511, 2017 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29073079
9.
The Role of Endophytic/Epiphytic Bacterial Constituents in the Immunostimulatory Activity of the Botanical, Astragalus membranaceus.
Yale J Biol Med
; 93(2): 239-250, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32607085
10.
Immunization of Pigs by DNA Prime and Recombinant Vaccinia Virus Boost To Identify and Rank African Swine Fever Virus Immunogenic and Protective Proteins.
J Virol
; 92(8)2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29386289
11.
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates.
J Virol
; 92(8)2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437967
12.
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
J Virol
; 91(9)2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28179536
13.
Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
J Virol
; 91(9)2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28202751
14.
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.
J Virol
; 90(8): 4133-4149, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26865719
15.
Genome-wide profiling of human cap-independent translation-enhancing elements.
Nat Methods
; 10(8): 747-50, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23770754
16.
Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.
J Virol
; 89(20): 10489-99, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26246580
17.
Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
J Virol
; 89(2): 970-88, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25355891
18.
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.
J Virol
; 89(12): 6462-80, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25855741
19.
Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1.
J Gen Virol
; 96(Pt 6): 1478-1483, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25667320
20.
Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC".
J Virol
; 93(21)2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31615930